 This study found that lyriglotide, a type of drug called a glucagon like peptide 1, GLP1, receptor agonist, may be effective in reducing binge eating episodes in adults with obesity. The study also showed that lyriglotide resulted in clinically meaningful weight loss. However, there was no statistically significant difference between the lyriglotide and placebo groups in terms of binge eating remission rates. This article was authored by Kelly C. Allison, Ariana M. Chow, Maya B. Bruzoss, and others.